Joining forces increases innovation
Janssen and Radboud
1 December 2022
Dr. Eng Kinga MatuĊa (KM), specialist in single-cell multi-omics and Jeroen Van Houdt (JH), Omics group leader at Janssen Pharmaceutica, answer three pressing questions about the successful collaboration in the single-cell technology project.